Logo
  • About
  • Contact
  • (888) 441-8033

Sarson Funds Announces Casper Stablecoin (csprUSD) Service Providers: Custodia Bank and BlockPass

INDIANAPOLIS, IN - Sarson Funds, a boutique manager in blockchain and trusted advisor to professional investors, web3 founders, and top 100 crypto projects, announced new service providers in the firm's recently launched stablecoin issuance business line. For Sarson Funds' rec...

View full release

Stonegate Updates Coverage on Isabella Bank Corporation (OTCQX: ISBA) 2023 Q3

DALLAS, TX -- October 31st, 2023 --  Isabella Bank Corporation (OTCQX: ISBA): Stonegate Capital Partners updates their coverage on Isabella Bank Corporation (OTCQX: ISBA). Business Overview Isabella Bank Corporation (the Company, the Bank, or Isabella) operates as a holding c...

View full release

Stonegate Updates Coverage on NCS Multistage Holdings, Inc. (NASDAQ: NCSM) 2023 Q3

DALLAS, TX -- October 31st, 2023 --  NCS Multistage Holdings, Inc. (NASDAQ: NCSM): Stonegate Capital Partners updates their coverage on NCS Multistage Holdings, Inc. (NASDAQ: NCSM).  BUSINESS OVERVIEW NCS Multistage Holdings, Inc. (“NCS”, “NCSM”, “NCS Multistage”, or “the Com...

View full release

BioUtah Announces New Board Leadership and Five New Board Members

Salt Lake City - October 27, 2023 - BioUtah, Utah’s trade association serving the state’s life sciences community, announced today Myles Greenberg, MD, MBA, CEO of Alucent Biomedical, as the new board chair, effective January 2024.  Dr. Greenberg, an experienced life sciences ...

View full release

Okogen, Inc., Announces Initiation of Phase IIb Clinical Trial for Pink Eye (Acute Infectious Conjunctivitis)

San Diego, CA – October 31, 2023 – Okogen, an ophthalmic biotechnology company, today announced the initiation of a Phase IIb clinical trial evaluating OKG-0303 for Acute Infectious Conjunctivitis (“Pink Eye”) to be conducted in India. Additionally, as part of the corporate re...

View full release

Stonegate Capital Partners Updates Coverage on Alliance Resource Partners, L.P. (NASDAQ: ARLP) 2023 Q3

DALLAS, TX -- October 30th, 2023 -- Alliance Resource Partners, L.P. (NASDAQ: ARLP): Stonegate Capital Partners updates coverage on Alliance Resource Partners, L.P.  ARLP Releases 3Q23 Earnings, Maintaining Momentum ARLP reported solid 3Q23 results that continued the trend of...

View full release

Stonegate Capital Partners Updates Coverage on Civeo Corporation (NYSE: CVEO) 2023 Q3

DALLAS, TX -- October 30th, 2023 --  Civeo Corporation (NYSE: CVEO): Stonegate Capital Partners updates their coverage on Civeo Corporation. Business Overview Civeo Corporation provides workforce accommodations and hospitality services in the United States, Canada, and Austra...

View full release

OHRC Lays Out Blueprint to Profile Canadian Hindus, Despite Affirming Existing Laws Cover Caste-based Discrimination

TORONTO, CA: In a partial win for Canadian Hindu groups, the Ontario Human Rights Commission (OHRC) recognized that current legislation and protections already address issues related to caste-based discrimination. However, the OHRC’s policy position echoes data that is general...

View full release

Stonegate Capital Partners Updates Coverage on International Personal Finance PLC (LSE: IPF) Q3 2023

DALLAS, TX -- October 27th, 2023 --  International Personal Finance PLC (LSE: IPF): Stonegate Capital Partners updates their coverage on International Personal Finance PLC. Business Overview International Personal Finance PLC (LSE: IPF) provides affordable consumer credit ser...

View full release

Kiora Sharpens Focus on Orphan Retinal Diseases

In early August 2023, Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) announced a sharpened clinical development focus on rare retinal diseases with large unmet needs, initially dedicating attention to inherited retinal diseases (IRDs). Kiora recently completed a Phase 1b study of ...

View full release
  • « First
  • ‹ Prev
  • …
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • …
  • Next ›
  • Last »
©2025 Reportable, Inc.
Terms and Conditions | Privacy Policy